Researchers are developing a new predictive tool that could help patients with breast cancer and certain lung cancers decide whether follow-up treatments are likely to help, reports [s]Medical Xpress[/s]. [b]Dr Jerry Shay[/b] of [b]University of Texas Southwestern[/b] led a three-year study on the effects of irradiation in a lung cancer-susceptible mouse model. When his team looked at gene expression changes in the mice, then applied them to humans with early stage cancer, the results revealed a breakdown of which patients have a high or low chance of survival. The findings, published online in [s]Clinical Cancer Research[/s], offer insight into helping patients assess treatment risk.
[link url=http://medicalxpress.com/news/2014-03-gene-cancer-treatments.html]Full Medical Xpress report[/link]
[link url=http://clincancerres.aacrjournals.org/content/20/6/1610.full?sid=450fe7ab-9058-43af-b557-ff0e4f028064]Clinical Cancer Research full report[/link]